Building on our work characterizing miRNA cargo in small extracellular vesicles (sEVs) from the epididymis (Fetal Programming), we initiated a collaboration with Dr. Keith Jarvi (Mount Sinai Hospital) to develop non-invasive diagnostic markers for prostate cancer using sEVs isolated from semen. This approach aims to improve early detection and reduce reliance on invasive prostate biopsies, which carry a risk of significant complications. Our work in this area has the potential to transform prostate cancer screening and diagnostic strategies.
